
Granules India Limited has informed the Exchange regarding a press release dated October 22, 2020, titled "Granules India received approval for Generic K-Dur, equivalent to Klor Con M, potassium chloride tablets for the treatment of Hypokalemia".
Filed with NSE ·

Granules India Limited has informed the Exchange regarding a press release dated October 22, 2020, titled "Granules India received approval for Generic K-Dur, equivalent to Klor Con M, potassium chloride tablets for the treatment of Hypokalemia".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India